Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Biocept awarded Canadian patent covering enhanced detection of rare cells » 08:08
06/30/20
06/30
08:08
06/30/20
08:08
BIOC

Biocept

$0.71 /

+0.07 (+11.01%)

Biocept announces that it…

Biocept announces that it has been awarded Canadian Patent 2812291, entitled "METHODS AND REAGENTS FOR SIGNAL AMPLIFICATION." This patent covers methods for enhancing the detection of cells using fluorescent complexes, including circulating tumor cells and from a biological fluid. The issuance of this patent increases Biocept's total patent awards for use in its molecular diagnostics business to 40.

ShowHide Related Items >><<
BIOC Biocept
$0.71 /

+0.07 (+11.01%)

BIOC Biocept
$0.71 /

+0.07 (+11.01%)

05/14/20 Brookline
Biocept initiated with a Buy at Brookline
  • 14
    Apr
Over a week ago
Hot Stocks
Biocept enters managed care provider agreement with MCCP » 08:08
06/24/20
06/24
08:08
06/24/20
08:08
BIOC

Biocept

$0.68 /

-0.0807 (-10.61%)

Biocept announces it has…

Biocept announces it has entered into a managed care provider agreement with Medical Cost Containment Professionals to process out-of-network claims for Biocept's Target Selector liquid biopsy testing. MCCP is a reference-based pricing insurance network that includes more than 150,000 providers nationwide.

ShowHide Related Items >><<
BIOC Biocept
$0.68 /

-0.0807 (-10.61%)

BIOC Biocept
$0.68 /

-0.0807 (-10.61%)

05/14/20 Brookline
Biocept initiated with a Buy at Brookline
Hot Stocks
Biocept: 10,000 specimen collection kits available for RT-PCR COVID-19 testing » 08:13
06/22/20
06/22
08:13
06/22/20
08:13
BIOC

Biocept

$0.85 /

-0.0762 (-8.22%)

Biocept announces the…

Biocept announces the availability of 10,000 nasopharyngeal specimen collection kits for RT-PCR testing for SAR-CoV-2 for physician ordering. Collected specimens will be shipped overnight to Biocept's high-complexity, CLIA-certified, CAP-accredited and BSL-2 safety level laboratory in San Diego with results returned to ordering physicians in an estimated 24 to 48 hours.

ShowHide Related Items >><<
BIOC Biocept
$0.85 /

-0.0762 (-8.22%)

BIOC Biocept
$0.85 /

-0.0762 (-8.22%)

05/14/20 Brookline
Biocept initiated with a Buy at Brookline
Hot Stocks
Biocept to relocate corporate offices, CLIA-certified laboratory to San Diego » 08:08
06/05/20
06/05
08:08
06/05/20
08:08
BIOC

Biocept

$0.54 /

+0.1008 (+23.10%)

Biocept announces that it…

Biocept announces that it is relocating its corporate offices and CLIA-certified, CAP-accredited high complexity laboratory to a new location in San Diego. The move is expected to be completed by 2020 year end. The company's new 39,000-square-foot headquarters, manufacturing and lab facility will be located at 9955 Mesa Rim Road, San Diego, CA 92121.

ShowHide Related Items >><<
BIOC Biocept
$0.54 /

+0.1008 (+23.10%)

BIOC Biocept
$0.54 /

+0.1008 (+23.10%)

05/14/20 Brookline
Biocept initiated with a Buy at Brookline
Over a month ago
Conference/Events
Maxim Group to hold a virtual conference » 09:25
05/27/20
05/27
09:25
05/27/20
09:25
APDN

Applied DNA Sciences

$11.78 /

+0.69 (+6.22%)

, BIOC

Biocept

$0.50 /

-0.0041 (-0.82%)

, BNGO

Bionano Genomics

$0.50 /

+0.0322 (+6.87%)

, CAPR

Capricor Therapeutics

$5.26 /

-0.13 (-2.41%)

, CODX

Co-Diagnostics

$18.03 /

-0.57 (-3.06%)

, DXR

Daxor

$14.00 /

-0.03 (-0.21%)

, LCTX

Lineage Cell Therapeutics

$1.04 /

+0.1806 (+21.01%)

, MESO

Mesoblast

$12.95 /

+0.76 (+6.23%)

, PSTI

Pluristem

$7.97 /

-0.39 (-4.67%)

, VNRX

VolitionRx

$3.11 /

+0.12 (+4.01%)

Maxim Group Virtual…

Maxim Group Virtual COVID-19 Conference will be held on May 27.

ShowHide Related Items >><<
VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

PSTI Pluristem
$7.97 /

-0.39 (-4.67%)

MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

LCTX Lineage Cell Therapeutics
$1.04 /

+0.1806 (+21.01%)

DXR Daxor
$14.00 /

-0.03 (-0.21%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

BNGO Bionano Genomics
$0.50 /

+0.0322 (+6.87%)

BIOC Biocept
$0.50 /

-0.0041 (-0.82%)

APDN Applied DNA Sciences
$11.78 /

+0.69 (+6.22%)

APDN Applied DNA Sciences
$11.78 /

+0.69 (+6.22%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
BIOC Biocept
$0.50 /

-0.0041 (-0.82%)

05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BNGO Bionano Genomics
$0.50 /

+0.0322 (+6.87%)

04/08/20 Oppenheimer
Oppenheimer bullish on Bionano Genomics, initiates with an Outperform
04/08/20 Oppenheimer
Bionano Genomics initiated with an Outperform at Oppenheimer
CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

02/03/20 Maxim
Capricor Therapeutics upgraded to Buy from Hold at Maxim
07/15/19 H.C. Wainwright
Capricor price target raised to $12.40 from $3.50 at H.C. Wainwright
CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright
03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
DXR Daxor
$14.00 /

-0.03 (-0.21%)

09/30/19 Roth Capital
Daxor initiated with a Neutral at Roth Capital
07/29/19
Daxor initiated with a Buy at Maxim
07/29/19 Maxim
Daxor initiated with a Buy at Maxim
LCTX Lineage Cell Therapeutics
$1.04 /

+0.1806 (+21.01%)

05/06/20 H.C. Wainwright
Lineage update shows OpRegen 'nicely on track,' says H.C. Wainwright
MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

04/09/20 H.C. Wainwright
H.C. Wainwright 'encouraged' by Mesoblast's plan to study Ryoncil in ARDS
10/22/19 Cantor Fitzgerald
Mesoblast assumed with an Overweight at Cantor Fitzgerald
09/10/19 Cantor Fitzgerald
Mesoblast partnership deal with Grunenthal a positive, says Cantor Fitzgerald
PSTI Pluristem
$7.97 /

-0.39 (-4.67%)

04/24/20 H.C. Wainwright
Pluristem removed overhang with loan agreement, says H.C. Wainwright
04/13/20 Maxim
Pluristem price target raised to $12 from $8 at Maxim
04/07/20 H.C. Wainwright
Early COVID-19 results 'a game changer' for Pluristem, says H.C. Wainwright
02/10/20 Dawson James
Pluristem could have 'blockbuster' therapy for CLI, says Dawson James
VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

05/06/20 Aegis
VolitionRx initiated with a Buy at Aegis
LCTX Lineage Cell Therapeutics
$1.04 /

+0.1806 (+21.01%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

BNGO Bionano Genomics
$0.50 /

+0.0322 (+6.87%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

APDN Applied DNA Sciences
$11.78 /

+0.69 (+6.22%)

VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

PSTI Pluristem
$7.97 /

-0.39 (-4.67%)

MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

Initiation
Biocept initiated with a Buy at Brookline » 11:07
05/14/20
05/14
11:07
05/14/20
11:07
BIOC

Biocept

$0.39 /

-0.0488 (-11.22%)

Brookline analyst Sally…

Brookline analyst Sally Yanchus initiated coverage of Biocept with a Buy rating and $2.06 price target.

ShowHide Related Items >><<
BIOC Biocept
$0.39 /

-0.0488 (-11.22%)

Hot Stocks
Biocept receives CE-IVD Mark for its EGFR Kit » 08:14
04/28/20
04/28
08:14
04/28/20
08:14
BIOC

Biocept

$0.39 /

+0.0015 (+0.39%)

Biocept announces the…

Biocept announces the award of CE, or Conformite Europeene,-IVD Mark for its Target Selector molecular assay EGFR Kit. The CE Mark confirms that the Company's Target Selector(TM) kit products meet the requirements of the European In-Vitro Diagnostic Devices Directive and allows Biocept to commercialize its kits throughout the European Union and other CE Mark geographies. Biocept's Target Selector molecular assay kits detect key oncogene mutations through the analysis of both Formalin-Fixed Paraffin-Embedded tissue gained from surgical biopsies as well as circulating tumor DNA gained from blood-based liquid biopsies.

Syndicate
Biocept files $100M mixed securities shelf  16:53
04/24/20
04/24
16:53
04/24/20
16:53
BIOC

Biocept

$0.39 /

-0.003 (-0.77%)

 
Syndicate
Biocept 22.3M share Spot Secondary priced at $0.46 » 09:23
04/14/20
04/14
09:23
04/14/20
09:23
BIOC

Biocept

$0.59 /

+0.2313 (+64.30%)

The registered direct…

The registered direct offering priced below the last closing price of $0.60. Maxim is acting as sole book running manager for the offering.

Hot Stocks
Biocept to begin COVID-19 testing » 19:28
04/09/20
04/09
19:28
04/09/20
19:28
BIOC

Biocept

$0.36 /

+0.0715 (+24.81%)

Biocept announces that it…

Biocept announces that it has verified a COVID-19 molecular diagnostic test, and plans to begin accepting physician-ordered testing requests for processing beginning on April 15, 2020. Biocept has partnered with a national clinician network to accept patient samples and may obtain additional agreements as test capacity is increased. Biocept operates a high-complexity, CLIA-certified, CAP-accredited and BSL-2 safety level laboratory in San Diego, with specialized, licensed molecular lab staff that have been trained in performing the COVID-19 testing. The lab will be using the FDA-approved for EUA testing ThermoFisher Scientific's TaqPath molecular diagnostic platform and kit for SARS-CoV-2.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.